EndoTAG�-1 On Phase II Trials Against Pancreatic Cancer

Filed in archive Drugs, Vaccines and Therapeutics by ruth on August 25, 2005

For the second day in a row, I' blogging about Paclitaxel. This time as a therapeutic against pancreatic cancer. Pancreatic cancer is the fourth leading cause of cancer-related mortality in the US.

MediGene AG announced the initiation of a phase II Clinical trial of drug candidate EndoTAGÖ1 (temporary name), a combination of paclitaxel and a unique carrier system which targets paclitaxel to newly formed blood vessels. EndoTAG� aims at starving cancerous tumors by destroying blood vessels and thereby cutting off nutrient supply.

Dr. Peter Heinrich, MediGene CEO, says

"Following several phase I/II trials in different indications with 151 patients showing safety and promising efficacy trends of EndoTAGÖ1, we are continuing the clinical development of this innovative drug candidate. The platform technology EndoTAG� has a great potential for the treatment of various solid, highly vascularized tumors. Therefore we plan to start further trials in other cancer indications in 2006."

Read MediGene's press release here.

Related Entries:

Antisoma Recruits Patients for AS1411 Extended Phase I Trial... - 06 September 2005
ENDEAVOUR: Computer Program For Identifying Disease Genes - 10 May 2006
Cell Therapeutics and Novartis Co-Develop Poliglumex Paclita... - 19 September 2006
Electric Device To Treat Brain Tumors Enters Phase III Clini... - 26 November 2006
DNA-Based Sputum Test for Detecting Early Stage Lung Cancer - 18 January 2007
Food-derived B Vitamins Can Decrease Risk of Pancreatic Canc... - 04 June 2007
Allergies May Protect Against Pancreatic Cancer - 31 December 2007
Phase 1 Trials Shows Plant-Produced Cancer Vaccine as Safe - 28 July 2008

« Industrial Scale Producti... | Main | Profos AG raises �5M in F... »

Permalink: EndoTAG�-1 On Phase II Trials Against Pancreatic Cancer

Tags: paclitaxel cancer biotech phase trials pancreatic+cancer against+pancreatic phase+trials

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/8663

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for EndoTAG�-1 On Phase II Trials Against Pancreatic Cancer:

Currently 6.00/10
1
2
3
4
5
6
7
8
9
10

Rating: 6.00 out of 4 vote(s) cast.

Add your response to EndoTAG�-1 On Phase II Trials Against Pancreatic Cancer:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Shawn Hessinger (1)
Gloria Gamat (5)
Ruth Schaffer (14)
Creative Weblogging (3)

This site has 1333 entries and is powered by Creative Weblogging since July 2005.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Are you interested in writing a blog in our network?

See which positions are currently open.

Testimonials

'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'